.Pharmacolibrary.Drugs.N_NervousSystem.N02A_Opioids.N02AA01_Morphine.Morphine .Pharmacolibrary.Drugs.N_NervousSystem.N02A_Opioids.N02AA01_Morphine.Morphine| name: | Morphine |
| ATC code: | N02AA01 | route: | intravenous |
| n-compartments | 2 |
Morphine is a potent opioid analgesic derived from opium and is primarily used for the relief of moderate to severe pain. It acts as an agonist at the mu-opioid receptor and is widely used in both acute and chronic pain management, including post-surgical, cancer, and palliative care settings. Morphine is an approved drug and is currently utilized globally for its analgesic properties.
Pharmacokinetic parameters in healthy adult subjects after intravenous administration.
Lugo, RA, & Kern, SE (2002). Clinical pharmacokinetics of morphine. Journal of pain & palliative care pharmacotherapy 16(4) 5–18. DOI:10.1080/j354v16n04_02 PUBMED:https://pubmed.ncbi.nlm.nih.gov/14635822
Brokjær, A, et al., & Drewes, AM (2015). Population pharmacokinetics of morphine and morphine-6-glucuronide following rectal administration--a dose escalation study. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 68 78–86. DOI:10.1016/j.ejps.2014.12.004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/25486331
Ihmsen, H, et al., & Jeleazcov, C (2021). Pharmacokinetics of Morphine and Morphine-6-Glucuronide During Postoperative Pain Therapy in Cardiac Surgery Patients. European journal of drug metabolism and pharmacokinetics 46(2) 249–263. DOI:10.1007/s13318-020-00663-z PUBMED:https://pubmed.ncbi.nlm.nih.gov/33547559